These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11132364)

  • 41. Self-modeling ordinal regression with time invariant covariates - An application to prostate cancer data.
    Shirazi AM; Das K; Pinheiro A
    Stat Methods Med Res; 2017 Oct; 26(5):2133-2154. PubMed ID: 26220536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceived barriers to smoking cessation among adults with substance use disorders.
    McHugh RK; Votaw VR; Fulciniti F; Connery HS; Griffin ML; Monti PM; Weiss RD
    J Subst Abuse Treat; 2017 Mar; 74():48-53. PubMed ID: 28132700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mixed effects models for recurrent events data with partially observed time-varying covariates: Ecological momentary assessment of smoking.
    Rathbun SL; Shiffman S
    Biometrics; 2016 Mar; 72(1):46-55. PubMed ID: 26410189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smoking cessation outcomes and predictors among individuals with co-occurring substance use and/or psychiatric disorders.
    Okoli CT; Khara M
    J Dual Diagn; 2014; 10(1):9-18. PubMed ID: 25392058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials.
    Barbieri A; Peyhardi J; Conroy T; Gourgou S; Lavergne C; Mollevi C
    BMC Med Res Methodol; 2017 Sep; 17(1):148. PubMed ID: 28950850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal Care Improves Cessation in Smokers Who Do Not Initially Respond to Treatment by Increasing Cessation Self-Efficacy, Satisfaction, and Readiness to Quit: A Mediated Moderation Analysis.
    Burns RJ; Rothman AJ; Fu SS; Lindgren B; Vock DM; Joseph AM
    Ann Behav Med; 2016 Feb; 50(1):58-69. PubMed ID: 26373657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Now you see it, now you don't: a comparison of traditional versus random-effects regression models in the analysis of longitudinal follow-up data from a clinical trial.
    Nich C; Carroll K
    J Consult Clin Psychol; 1997 Apr; 65(2):252-61. PubMed ID: 9086688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects.
    Twisk J; Rijmen F
    J Clin Epidemiol; 2009 Sep; 62(9):953-8. PubMed ID: 19211221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Random effects probit and logistic regression models for three-level data.
    Gibbons RD; Hedeker D
    Biometrics; 1997 Dec; 53(4):1527-37. PubMed ID: 9423267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.
    Xie H; Drake R; McHugo G
    Adm Policy Ment Health; 2006 Jul; 33(4):423-32. PubMed ID: 16691463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in studies on acupuncture abstinence.
    Cui M
    J Tradit Chin Med; 1995 Dec; 15(4):301-7, contd. PubMed ID: 8709614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of substance abuse treatment outcomes over time.
    Alemi F; Baghi H
    Qual Manag Health Care; 2010; 19(2):129-36. PubMed ID: 20351539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An initial meta-analysis of Acceptance and Commitment Therapy for treating substance use disorders.
    Lee EB; An W; Levin ME; Twohig MP
    Drug Alcohol Depend; 2015 Oct; 155():1-7. PubMed ID: 26298552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling intensive longitudinal data with mixtures of nonparametric trajectories and time-varying effects.
    Dziak JJ; Li R; Tan X; Shiffman S; Shiyko MP
    Psychol Methods; 2015 Dec; 20(4):444-69. PubMed ID: 26390169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Random-effect models for ordinal responses: application to self-reported disability among older persons.
    Carrière I; Bouyer J
    Rev Epidemiol Sante Publique; 2006 Feb; 54(1):61-72. PubMed ID: 16609638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group.
    Harrell FE; Margolis PA; Gove S; Mason KE; Mulholland EK; Lehmann D; Muhe L; Gatchalian S; Eichenwald HF
    Stat Med; 1998 Apr; 17(8):909-44. PubMed ID: 9595619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testing for omitted variables and non-linearity in regression models for longitudinal data.
    Palta M; Yao TJ; Velu R
    Stat Med; 1994 Nov; 13(21):2219-31. PubMed ID: 7846421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
    Bullen C; Verbiest M; Galea-Singer S; Kurdziel T; Laking G; Newcombe D; Parag V; Walker N
    BMC Public Health; 2018 May; 18(1):596. PubMed ID: 29728074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statistical assessment of ordinal outcomes in comparative studies.
    Scott SC; Goldberg MS; Mayo NE
    J Clin Epidemiol; 1997 Jan; 50(1):45-55. PubMed ID: 9048689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36).
    Walters SJ; Campbell MJ
    Health Qual Life Outcomes; 2004 Dec; 2():70. PubMed ID: 15588308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.